In breast cancer, a role for SATB1 as being a master switch towards a metastatic phenotype and a marker of poor prognosis has been demonstrated in a study including immunohistochemical analysis of >1000 human breast cancer specimens (Han et al, 2008). This evidence concerns the gene SATB1 and breast carcinoma.